QQ客服 官方微博 反馈留言

	A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
	Liu, Jiye; Song, Tianyu; Zhou, Wenrong; Xing, Lijie; Wang, Su; Ho, Matthew; Peng, Zhengang; Tai, Yu-Tzu; Hideshima, Teru; Anderson, 更多
刊名	LEUKEMIA
	2019
卷号	33期号:1页码:171-180
DOI	10.1038/s41375-018-0205-y
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4533270
专题	山东大学
作者单位	Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jero
推荐引用方式 GB/T 7714	Liu, Jiye,Song, Tianyu,Zhou, Wenrong,et al. A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity[J]. LEUKEMIA,2019,33(1):171-180.
APA	Liu, Jiye.,Song, Tianyu.,Zhou, Wenrong.,Xing, Lijie.,Wang, Su.,...&Anderson, 更多.(2019).A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity.LEUKEMIA,33(1),171-180.
MLA	Liu, Jiye,et al."A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity".LEUKEMIA 33.1(2019):171-180.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。